Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1984;64:12-15
© 1984 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BHAGAVAN, B. S.
Right arrow Articles by STOLLEY, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BHAGAVAN, B. S.
Right arrow Articles by STOLLEY, P. D.

Comparison of Estrogen-Induced Hyperplasia to Endometrial Carcinoma

BELUR S. BHAGAVAN, MD, TIM H. PARMLEY, MD, NEIL B. ROSENSHEIN, MD, JOAN L. JEFFERYS, ScM, JEANE-ANN GRISSO, MD and PAUL D. STOLLEY, MD, MPH

From the Division of Anatomic Pathology, Sinai Hospital of Baltimore and the School of Medicine, Johns Hopkins University, the Department of Gynecology and Obstetrics and Division of Gynecologic Oncology, Johns Hopkins Hospital, the Department of Epidemiology, Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland; and the Clinical Epidemiology Unit, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Use of exogenous estrogens has been associated with endometrial cancer in a number of case-control studies. This observed association could be biased as a result of frequent misclassification of estrogen-induced hyperplasia as endometrial cancer. To evaluate this possibility, pathology slides from 233 patients with a hospital diagnosis of endometrial cancer were reviewed independently by two pathologists. The hospital diagnosis was confirmed by both pathologists in 86% of the cases, indicating that the misclassification of hyperplasia as carcinoma is uncommon.




This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
B. L. Strom, R. Schinnar, A. L. Weber, G. Bunin, J. A. Berlin, M. Baumgarten, A. DeMichele, S. C. Rubin, M. Berlin, A. B. Troxel, et al.
Case-Control Study of Postmenopausal Hormone Replacement Therapy and Endometrial Cancer
Am. J. Epidemiol., October 15, 2006; 164(8): 775 - 786.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American College of Obstetricians and Gynecologists.